and others. Kirovs Lipmans, Chairman of the Council of Grindeks, highlights: "Expanding into new export markets is a testament to our long-term vision and dedication to global healthcare. By continuously investing in innovation, quality, and...
excipients. Serious hypersensitivity reactions, including reports of fatal anaphylaxis have been reported. Consider skin testing prior to treatment in patients with suspected hypersensitivity to calcitonin-salmon. Hypocalcemia has been reported....
Thrive, a leading provider of personalized healthcare solutions and a trusted partner of O2 Fitness, now offers KYZATREX® (testosterone undecanoate) CIII capsules to its patients nationwide. KYZATREX is an FDA-approved oral testosterone therapy...
in early-stage pharmaceutical research and development, elevating drugs from the bench to pre-clinical and clinical testing. Utilizing a patient-centric approach, we collaborate and partner with a team of scientists, clinicians, and key opinion...
Lab, Kofa Healthcare, and Global Brain in this financing. Zafrens' breakthrough platform allows scientists to create and test hundreds of thousands of potential medicines in a single experiment – a dramatic improvement over traditional drug...
Datar Cancer Genetics (DCG) has launched a revolutionary video-reporting service for in-vitro chemosensitivity testing, powered by AI-driven technology. This innovation provides oncologists with real-time visual evidence of chemotherapy drugs'...
protein research, enzyme technology, genome editing, omics research, pharmaceutical development, service and testing and cell culture. This adds to existing Biology innovations to increase lab productivity from the Life Science business of Merck...
"A key objective for Secretome in 2025 is to produce STM-01 drug product that is suitable for late-stage clinical testing and potential commercial use," said Vinny Jindal, President and CEO of Secretome Therapeutics. "Cellipont's world-class...
nested format available in multiple configurations at this year's Pharmapack event in Paris, France. This marks West's latest product offering supporting the needs of advanced therapies, one of the fastest growing areas, driven by continued...
Quantum-Si Incorporated The Protein Sequencing Company™, announces the launch of Platinum® Pro, its latest benchtop sequencer that sets a new standard in protein analysis. Designed to redefine efficiency and versatility in proteomics research,...
1 study was recently completed in healthy volunteers and showed MTX-463 to be well-tolerated and engaged WISP1 at all tested doses. The Phase 2 IPF study is designed to evaluate safety, pharmacokinetics, and efficacy in patients. The trial is...
interface. High-throughput screening and design of cyclic peptides using the platform's extensive library. Synthesis and testing of 29 candidate molecules. The results were impressive, with 12 compounds showing strong inhibition of protein-protein...
for earlier diagnosis and better patient outcomes. Strategic Partnership Impact: "Our partnership with eMBR Genomics is a testament to our shared mission of accelerating scientific discovery and improving patient outcomes," said Justin Byers,...
Tips, specifically designed with a drill/flute configuration for easier insertion, which may reduce thermal necrosis. In testing, the Cold Forged Tip Technology maintained precision sharpness OVER 50 uses. Keeping with Fusion’s aim to provide...
BK virus disease progression. This model deepens understanding of disease mechanisms and provides a robust platform for testing therapies, solidifying Orthogon’s leadership in addressing barriers to polyomavirus treatments. The company’s...
administration across care settings. We are encouraged by the initial promising safety and efficacy data at both doses tested in the expansion arm." Initial Clinical Data from Phase 1b LOTIS-7 Trial: LOTIS-7 is an ongoing Phase 1b global...
by Petauri™. Over time, Oak Hill will invest more than $250 million of equity capital in this initiative from its latest fund (OHCP VI). The platform works with pharmaceutical and life sciences clients to improve patient outcomes by establishing...
ODD qualifies the sponsor of the drug for certain development incentives, including tax credits for qualified clinical testing, prescription drug user fee exemptions and 7 years marketing exclusivity upon FDA approval. About Liver and Intrahepatic...
levels, further validating BLX-7006's potential translation into future human clinical trials. "These results are a testament to the strength of our BLX-7006 program and the dedication of our team in developing novel metabolic therapeutics," said...
His newly treated patients might show significant improvements on their eye chart tests, but Aaron Nagiel, MD, PhD, will tell you that the truest signs of visual progress come through the texts he receives from parents days, weeks, and months...
